Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK Correspondence to: Dr R Al-Shahi, Bramwell Dott Building, Department of Clinical Neurosciences, ...

Objective To explore whether age at onset increased over time despite a shortened interval from the initial clinical demyelinating event to the diagnosis of multiple sclerosis (MS), as promoted by ...

2 Department of Neurology, Kosei Chuo General Hospital, Tokyo, Japan 3 Department of Neurology, National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa, Japan 4 Department of ...

Background Recent research has shown that behavioural symptoms in Huntington’s disease (HD) have a significant impact on patients’ quality of life and function. Accurate assessment of behavioural ...

Saccades, including fast phases of nystagmus, disappear during drowsiness and non-rapid eye movement (NREM) sleep, but are present during the alert state and REM sleep. The purpose of this study was ...

Background Δ9-tetrahydrocannabinol (Δ9-THC) is neuroprotective in models of Parkinson's disease (PD). Although CB1 receptors are increased within the basal ganglia of PD patients and animal models, ...

Introduction Electrodiagnostic evaluation is crucial in establishing the diagnosis of motor neuron disease (MND) and excluding other pathologies. It is recommended that sensory nerve conduction ...